Home
HelpTest ID CDAU5 Drug Abuse Survey with Confirmation, Panel 5, Urine
Useful For
Detecting drug abuse involving amphetamines, cocaine, marijuana, opiates, and phencyclidine
This test is intended to be used in a setting where the test results can be used definitively to make a diagnosis.
Some drug treatment programs do not require confirmatory testing of screen-positive specimens. In those settings, UDOA / Drug Abuse Survey, Urine is a less costly option.
Reflex Tests
| Test ID | Reporting Name | Available Separately | Always Performed |
|---|---|---|---|
| AMPHU | Amphetamines Confirmation, U | Yes | No |
| COKEU | Cocaine and metabolite Conf, U | Yes | No |
| OPATU | Opiate Confirmation, U | Yes | No |
| PCPU | Phencyclidine Confirmation, U | Yes | No |
| THCU | Carboxy-THC Confirmation, U | Yes | No |
Testing Algorithm
Testing begins with immunoassay screen. Positives are confirmed and quantitated by gas chromatography-mass spectrometry or liquid chromatography-tandem mass spectrometry at an additional charge.
Method Name
Screened by Immunoassay
Reporting Name
Confirmed Drug Abuse Panel 5, USpecimen Type
UrineCollection Container/Tube: Plastic urine container
Submission Container/Tube: Plastic, 60-mL urine bottle
Specimen Volume: 30 mL
Collection Instructions:
1. Collect a random urine specimen.
2. Submit 30 mL in 1 plastic bottle.
3. No preservative.
Additional Information:
1. No specimen substitutions.
2. No STATS are accepted for this procedure.
3. For situations where chain of custody is required, a Chain-of-Custody Kit (T282) is available. For chain-of-custody testing, order CDA5X / Drug Abuse Survey with Confirmation, Panel 5, Chain of Custody, Urine.
4. Additional drug panels and specific requests are available. Call Mayo Medical Laboratories at 800-533-1710 or 507-266-5700.
5. If urine creatinine is required or adulteration of the sample is suspected, the following test should be requested, ADULT / Adulterants Survey, Urine. For additional information, please refer to ADULT / Adulterants Survey, Urine.
6. Submitting less than 30 mL will compromise our ability to perform all necessary testing.
Forms: Chain-of-Custody Request Form is included in the Chain-of-Custody Kit (T282). A copy of this form is also available at http://www.mayomedicallaboratories.com/it-mmfiles/chain-of-custody-request-form.pdf.
Specimen Minimum Volume
15 mL
Specimen Stability Information
| Specimen Type | Temperature | Time |
|---|---|---|
| Urine | Refrigerated (preferred) | 14 days |
| Frozen | 14 days | |
| Ambient | 72 hours |
Clinical Information
This assay was designed to screen for and confirm by gas chromatography-mass spectrometry (GC-MS) or liquid chromatography-tandem mass spectrometry (LC-MS/MS) for the following drugs:
-Amphetamines
-Cocaine
-Opiates
-Phencyclidine
-Tetrahydrocannabinol
This assay represents the coupling of UDOA / Drug Abuse Survey, Urine with an automatic confirmation of all positive results by the definitive assay available and described elsewhere (eg, AMPHU / Amphetamines Confirmation, Urine). All positive screening results are confirmed by GC-MS or LC-MS/MS, and quantitated, before a positive result is reported.
Reference Values
Negative
Screening cutoff concentrations
Amphetamines: 500 ng/mL
Cocaine (benzoylecgonine-cocaine metabolite): 150 ng/mL
Opiates: 300 ng/mL
Phencyclidine: 25 ng/mL
Tetrahydrocannabinol carboxylic acid: 50 ng/mL
This report is intended for use in clinical monitoring or management of patients. It is not intended for use in employment-related testing.
Cautions
Not intended for use in employment-related testing.
The test does not screen for drug classes other than those listed above. More comprehensive screening is available using DSS / Drug Screen, Prescription/OTC, Serum or PDSU / Drug Screen, Prescription/OTC, Urine.
For situations where chain of custody is required, a Chain-of-Custody Kit (T282) is available. See CDA5X / Drug Abuse Survey with Confirmation, Panel 5, Chain of Custody, Urine.
Day(s) Performed
Monday through Sunday
Report Available
Same day/1 dayPerforming Laboratory
Mayo Medical Laboratories in Rochester
Test Classification
This test has been cleared or approved by the U.S. Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.CPT Code Information
80301
G0479 (if appropriate)
See individual reflex tests for appropriate CPT codes